This study aimed to determine the proportion of patients facing CHE and estimate the OOP payments among the households of patients who underwent PCI and CABG in Shiraz, Iran, during 2019 - 2021 in public and PPP hospitals. We found that OOP payment among PPP hospitals was 76953100 R/2506.78 $ (SD = 53247600 R/1734.56 $) in the PCI group and 230937700 R/7522.89 $ (SD = 248295200 R/8088.32 $) in the CABG group. This value in public hospitals was 15083800 R/491.36 $ (SD = 18637600 R/607.13 $) in the PCI group and 12276800 R/399.92 $ (SD = 11131900 R/362.63 $) in the CABG group. Our results showed that admission duration, age, type of hospital, and being currently a smoker significantly impacted OOP payment.
During baseline assessment, we found that the percentage of PCI patients that faced CHE was 95.56% and 47.92% in PPP and public hospitals, respectively. This value in the CABG patients was 92.31% and 40.45%. Our study showed that the type of hospital and SES were significant factors that push a family facing CHE.
We estimated the OOP payments among households of patients who underwent CABG and PCI in different hospital types. A study conducted in 2016 compared OOP costs in 8 Asian countries and showed that OOP payments had a broad range across countries. For example, in Malaysia, mean OOP costs were 69 US$ for ST-elevation myocardial infarction (MI), while in China, this value was 4047 US$ (
22). Another study during 2018 - 2019 in Iran showed that the direct medical costs of CABG were about 183,907,460 Rials, and PCI was about 122,508,920 Rials in Tehran Heart Center, which is different from our finding (
23). It could be due to the type of hospitals the study has not mentioned and different medical services prices in both cities (Tehran vs. Shiraz). In another study, OOP costs were estimated to be 16 million Rials per year for cardiovascular patients in 2015 (
24).
Our results showed that admission duration, age, types of hospital, and being a smoker significantly affected OOP costs. The longer the duration of stay, the higher the OOP costs. Other studies confirmed our findings (
25-
27). When a patient's hospital stay is prolonged, their medical costs increase. In our study, age was inversely associated with OOP expenditure. In contrast, a study from Bangladesh found that age group was significantly associated with higher OOP costs (
28). One explanation for this result is that we analyzed the data of households for OOP, and the age variant is only for the patients who underwent the procedure.
Our study showed that types of hospitals have an association with OOP expenditures. The PPP hospital has a 5.3 times higher chance of having more patients with OOP costs. That is because the insurance coverage for PPP hospitals is lower than that for public hospitals. Implementing the "health system reform" in Iran significantly reduced the proportion of OOP expenses for patients undergoing operations in public hospitals. The costs are now covered by the Ministry of Health in Iran (
29). Hospital A is also a public hospital, and our results showed that patients' OOP was about 2.6 times higher in this hospital than in hospital F. Another study by Maharlou et al. showed the same results that hospital types have a significant effect on OOP (
29). One explanation is the possibility of severity of the disease. Severe patients may be referred to hospital A, so the OOP expenditures differ. Another explanation is the possible effect of hospital A being a teaching center for cardiologist residents, which may affect the OOP expenditures. However, we recommend further investigations and research.
We found that being a current smoker was an independent predictor of less OOP. This was also correct for the hookah; however, it was non-significant. No previous research has assessed "being a smoker" and its impact on OOP. The possible explanations need more investigations with a larger sample size and on the difference of the elasticity of demand for healthcare compared to the cigarette in households of current smokers compared to the normal population. As mentioned before, we analyzed the variables on a household level, and "being a current smoker" is a characteristic specific to the patient only.
We estimated the proportion of patients who underwent CABG and PCI that faced CHE. Worldwide, a cross-sectional study performed in Ibadan, Nigeria, in 2022 found that catastrophic OOP payments ranged between 3.9% and 54.6% (
30). Also, in another study, CHE was reported by 66% of those without insurance versus 52% of those with health insurance (
22). In Iran, a cohort study showed that the proportion of households facing CHE had no significant change from 2003 (12.6%) to 2008 (11.8%) (
14). Also, another study in Iran in 2017 demonstrated that 55% of patients faced catastrophic expenditures (
24). In our study, CHE was above 90% in PPP hospitals and about 40% in public hospitals at the baseline, which is too much for patients who face it. The government must pay special attention to facilitating cardiovascular services for patients. Decimals of the population can be a good indicator for policymakers to be concerned about this problem.
Our study showed that the type of hospital and SES significantly affected the likelihood of patients facing CHE. As we discussed the types of hospitals and OOP before, the same applies to the chance of CHE. The more one pays for medical expenses, the higher the likelihood of facing CHE.
Our study categorized patients as poor, middle, and rich concerning SES. The results showed that having poor status doubles the chance of facing CHE. A systematic review conducted by Azzani et al. found that socioeconomic inequality plays an important role in facing CHE, and low-income households are at a high risk of financial hardship of medical expenditures (
31). Also, Emamgholipour et al. found that income level negatively impacts CHE (
24).
5.1. A Picture of OOP and CHE Over Time
Looking at the goals of HSEP, it seems that the CHE proportions found in this study are far more than its goal. Assessment of Iran's HSEP shortly after implementation showed a decreased percentage of direct patients' costs and OOP. However, the net value of payment and expenses were even increased. Most previous studies were cross-sectional and could not present a picture of the OOP and CHE during time. For this group of patients, we emphasize further investigation into the causes of the non-success of HSEP toward its goal (
32).
The biggest strength of our study was its design, which followed patients prospectively. We followed our participants for one year by making phone calls every three months. Our sample size was another strength. We also included socioeconomic factors in our analytic methods to find effective factors in facing CHE. We even used appropriate and strong models to analyze our data.
The limitation of our study was the loss of participants during follow-up periods. We suggest that future studies should include private hospitals, other cities, and other factors that can affect CHE and OOP, such as insurance coverage, in their analysis.
In conclusion, we found that the baseline CHE is very high for both PCI and CABG patients. Thus, the government should pay special attention to this issue. We also found that admission duration, age, type of hospital, and being a smoker significantly affected OOP, and type of hospital and SES significantly affected CHE. The baseline CHE was very high, so the government should pay special attention to this issue. Finally, we recommend further investigating the effect of "age" and "being a smoker" on OOP.